Chiranjit Chowdhury

Dr. Chiranjit Chowdhury

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Microbiology and Molecular Biology Reviews
Verified
Journal Article
Closed access
PDF file
CCChiranjit Chowdhury
Chiranjit Chowdhury
SSSharmistha Sinha
Sharmistha Sinha
SCSunny Chun
Sunny Chun
TYTodd O Yeates
Todd O Yeates
TBThomas A. Bobik
Thomas A. Bobik
SUMMARY: Bacterial microcompartments (MCPs) are sophisticated protein-based organelles used to optimize metabolic pathways. They consist of metabolic enzymes encapsulated within a protein shell, which creates an ideal environment for catalysis and facilitates the channeling of toxic/volatile intermediates to downstream enzymes. The metabolic processes that require MCPs are diverse and widely distributed and play important roles in global carbon fixation and bacterial pathogenesis. The protein shells of MCPs are thought to selectively control the movement of enzyme cofactors, substrates, and products (including toxic or volatile intermediates) between the MCP interior and the cytoplasm of the cell using both passive electrostatic/steric and dynamic gated mechanisms. Evidence suggests that specialized shell proteins conduct electrons between the cytoplasm and the lumen of the MCP and/or help rebuild damaged iron-sulfur centers in the encapsulated enzymes. The MCP shell is elaborated through a family of small proteins whose structural core is known as a bacterial microcompartment (BMC) domain. BMC domain proteins oligomerize into flat, hexagonally shaped tiles, which assemble into extended protein sheets that form the facets of the shell. Shape complementarity along the edges allows different types of BMC domain proteins to form mixed sheets, while sequence variation provides functional diversification. Recent studies have also revealed targeting sequences that mediate protein encapsulation within MCPs, scaffolding proteins that organize lumen enzymes and the use of private cofactor pools (NAD/H and coenzyme A [HS-CoA]) to facilitate cofactor homeostasis. Although much remains to be learned, our growing understanding of MCPs is providing a basis for bioengineering of protein-based containers for the production of chemicals/pharmaceuticals and for use as molecular delivery vehicles.

1 July 2008 in Trends in Microbiology
Verified
Journal Article
Closed access
AGAnindya Sundar Ghosh
Anindya Sundar Ghosh
CCChiranjit Chowdhury
Chiranjit Chowdhury
DNDavid E. Nelson
David E. Nelson

23 February 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
CCChiranjit Chowdhury
Chiranjit Chowdhury
SCSunny Chun
Sunny Chun
APAllan Pang
Allan Pang
MSMichael R. Sawaya
Michael R. Sawaya
SSSharmistha Sinha
Sharmistha Sinha
TBThomas A. Bobik
Thomas A. Bobik
Significance: Here, we describe a type of selective channel formed by a nonmembrane protein that is used to control metabolite movement between cellular compartments. In this case, the channel controls the movement of metabolites between the bacterial cytoplasm and the lumen of a bacterial microcompartment, a primitive organelle that is bounded by a protein shell and lacks any lipid bilayer. These studies are the first to our knowledge to prove selective molecular transport through a protein-based barrier. These findings broaden our understanding of how cells control the movement of molecules between cellular compartments, which is fundamental to biological systems. It also solves a key question about the function of bacterial microcompartments, which themselves impact many diverse and important biological processes.

1 January 2013 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
CCChiranjit Chowdhury
Chiranjit Chowdhury
MJMedicharla Venkata Jagannadham
Medicharla Venkata Jagannadham

15 May 2018 in Journal of Bacteriology
Verified
Journal Article
Closed access
THTaylor I. Herring
Taylor I. Herring
THTiffany N. Harris
Tiffany N. Harris
CCChiranjit Chowdhury
Chiranjit Chowdhury
SMSujit Kumar Mohanty
Sujit Kumar Mohanty
TBThomas A. Bobik
Thomas A. Bobik
Bacterial choline degradation in the human gut has been associated with cancer and heart disease. In addition, recent studies found that a bacterial microcompartment is involved in choline utilization byProteusandDesulfovibriospecies. However, many aspects of this process have not been fully defined. Here, we investigate choline degradation by the uropathogenEscherichia coli536. Growth studies indicatedE. coli536 degrades choline primarily by fermentation. Electron microscopy indicated that a bacterial microcompartment was used for this process. Bioinformatic analyses suggested that the choline utilization (cut) gene cluster ofE. coli536 includes two operons, one containing three genes and a main operon of 13 genes. Regulatory studies indicate that thecutXgene encodes a positive transcriptional regulator required for induction of the maincutoperon in response to choline supplementation. Each of the 16 genes in thecutcluster was individually deleted, and phenotypes were examined. ThecutX,cutY,cutF,cutO,cutC,cutD,cutU, andcutVgenes were required for choline degradation, but the remaining genes of thecutcluster were not essential under the conditions used. The reasons for these varied phenotypes are discussed.IMPORTANCEHere, we investigate choline degradation inE. coli536. These studies provide a basis for understanding a new type of bacterial microcompartment and may provide deeper insight into the link between choline degradation in the human gut and cancer and heart disease. These are also the first studies of choline degradation inE. coli536, an organism for which sophisticated genetic analysis methods are available. In addition, thecutgene cluster ofE. coli536 is located in pathogenicity island II (PAI-II536) and hence might contribute to pathogenesis.

15 April 2017 in Journal of Bacteriology
Verified
Journal Article
Closed access
PDF file
BLBrent P. Lehman
Brent P. Lehman
CCChiranjit Chowdhury
Chiranjit Chowdhury
TBThomas A. Bobik
Thomas A. Bobik
Bacterial microcompartments (MCPs) are extremely large proteinaceous organelles that consist of an enzymatic core encapsulated within a complex protein shell. A key question in MCP biology is the nature of the interactions that guide the assembly of thousands of protein subunits into a well-ordered metabolic compartment. In this report, we show that the N-terminal 37 amino acids of the PduB protein have a critical role in binding the shell of the 1,2-propanediol utilization (Pdu) microcompartment to its enzymatic core. Several mutations were constructed that deleted short regions of the N terminus of PduB. Growth tests indicated that three of these deletions were impaired MCP assembly. Attempts to purify MCPs from these mutants, followed by gel electrophoresis and enzyme assays, indicated that the protein complexes isolated consisted of MCP shells depleted of core enzymes. Electron microscopy substantiated these findings by identifying apparently empty MCP shells but not intact MCPs. Analyses of 13 site-directed mutants indicated that the key region of the N terminus of PduB required for MCP assembly is a putative helix spanning residues 6 to 18. Considering the findings presented here together with prior work, we propose a new model for MCP assembly. IMPORTANCE Bacterial microcompartments consist of metabolic enzymes encapsulated within a protein shell and are widely used to optimize metabolic process. Here, we show that the N-terminal 37 amino acids of the PduB shell protein are essential for assembly of the 1,2-propanediol utilization microcompartment. The results indicate that it plays a key role in binding the outer shell to the enzymatic core. We propose that this interaction might be used to define the relative orientation of the shell with respect to the core. This finding is of fundamental importance to our understanding of microcompartment assembly and may have application to engineering microcompartments as nanobioreactors for chemical production.